Hydrogenology
Source-linked study record

The reason for the amelioration of N-methyl-N-nitrosourea-induced retinitis pigmentosa in rats by hydrogen-rich saline

Yan WM, Chen T, Wang XC, Qi LS, Zhao GH, Yang GQ, Ma YF, Tao Y, Zhang L, Zhang ZM. · International Journal of Ophthalmology. 2017;10(10):1495-1503.

PreclinicalOther formsPublished 2017Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Seventy-two rats allocated to normal, MNU retinal-degeneration model, and MNU plus H₂-rich saline groups.

Intervention and dose

H₂-rich saline 10 mL/kg intraperitoneally once daily from 14 days before MNU administration until sacrifice one or three days afterward. · Purified hydrogen was dissolved in saline for six hours at 0.4 MPa; solution was stored at 4°C, made weekly and confirmed by gas chromatography to remain above 0.6 mmol/L.

Duration

Daily pretreatment for 14 days plus continued dosing until day-1 or day-3 assessment after MNU.

Reported result

H₂-rich saline preserved retinal structure and b-wave amplitude and was associated with higher Sirt1 by day 3. Microglial/Iba1 measures were higher than the untreated model on day 1 but lower by day 3; Sirt1 mRNA was higher at both points but statistically significant at day 3, and Sirt1 protein differed significantly at day 3. The short study did not test inherited retinitis pigmentosa or durable vision.

Main limitation

Chemical retinal-injury model, prophylactic H₂ exposure beginning 14 days before injury, short one-to-three-day follow-up, small molecular assay samples and no human participants. Chinese national/provincial grants funded the work; every author declared no conflict of interest.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Randomized three-group controlled rat study

Research topic

Eye health

Administration form

Other forms

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Seventy-two rats allocated to normal, MNU retinal-degeneration model, and MNU plus H₂-rich saline groups.

Sample

72 rats, n=24 per group. Functional/histological time-point analyses used n=6 per group and molecular assays commonly used n=3 per group.

Duration

Daily pretreatment for 14 days plus continued dosing until day-1 or day-3 assessment after MNU.

Intervention

H₂-rich saline 10 mL/kg intraperitoneally once daily from 14 days before MNU administration until sacrifice one or three days afterward.

Hydrogen form

H₂ dissolved in saline — H₂ only, not Brown's gas.

Dose or H₂ specification

Purified hydrogen was dissolved in saline for six hours at 0.4 MPa; solution was stored at 4°C, made weekly and confirmed by gas chromatography to remain above 0.6 mmol/L.

Comparator

Normal rats and MNU model rats receiving equal-volume normal saline.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Outer nuclear-layer thickness, electroretinographic b-wave, retinal microglia/Iba1 and Sirt1 mRNA and protein.

Reported result

H₂-rich saline preserved retinal structure and b-wave amplitude and was associated with higher Sirt1 by day 3. Microglial/Iba1 measures were higher than the untreated model on day 1 but lower by day 3; Sirt1 mRNA was higher at both points but statistically significant at day 3, and Sirt1 protein differed significantly at day 3. The short study did not test inherited retinitis pigmentosa or durable vision.

Extraction completeness

The complete free PMC article was checked for allocation, H₂ preparation and concentration, dose, prophylactic schedule, structural, functional and molecular results including time-dependent/null findings, funding and conflict declarations.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Chemical retinal-injury model, prophylactic H₂ exposure beginning 14 days before injury, short one-to-three-day follow-up, small molecular assay samples and no human participants. Chinese national/provincial grants funded the work; every author declared no conflict of interest.

Applies directly to

Acute MNU-induced photoreceptor degeneration in rats; it does not establish treatment for inherited retinitis pigmentosa in people.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 29062766 · DOI: 10.18240/ijo.2017.10.03

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.